Ligand validation:1HVY

D16: TOMUDEX

D16 is a Ligand Of Interest in 1HVY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1HVY_D16_D_417	63%	7%	0.122	0.917	1.84	2.91	5	11	1	0	100%	1
1HVY_D16_A_414	56%	8%	0.134	0.906	1.82	2.87	5	11	1	0	100%	1
1HVY_D16_C_416	55%	7%	0.15	0.92	1.75	2.98	4	11	0	0	100%	1
1HVY_D16_B_415	47%	7%	0.146	0.884	1.86	2.85	5	11	1	0	100%	1
6ZXO_D16_B_401	74%	29%	0.125	0.954	1.42	1.44	3	5	2	0	100%	1
5X5Q_D16_A_402	43%	14%	0.183	0.907	1.99	1.84	14	4	0	0	100%	1
1I00_D16_A_315	16%	13%	0.221	0.787	1.97	2.02	8	11	2	0	100%	1
7XYK_D16_D_302	89%	73%	0.076	0.956	0.36	0.68	-	1	0	0	100%	1
4EB4_D16_A_402	79%	24%	0.086	0.931	1.45	1.68	4	7	1	0	100%	1
8GKF_D16_B_301	72%	52%	0.131	0.954	0.76	1.09	-	2	0	0	100%	1
3NRR_D16_A_530	71%	29%	0.112	0.933	1.59	1.28	5	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.